SCHEMBL21781977

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(NC(=O)[C@H](CCCNC(N)O)NC(=O)[C@@H](NC(=O)CCC(=O)N2CC[C@H](C(=O)Oc3c(F)c(F)c(F)c(F)c3F)C[C@@H]2C)C(C)C)cc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	CYP3A4	P08684	1/20	0.47

▸	FOLH1	Q04609	3/20	0.43

▸	TTR	P02766	2/20	0.40

▸	SSTR2	P30874	2/20	0.38

▸	AKT1	P31749	3/20	0.34

▸	NECTIN4	Q96NY8	1/20	0.33

▸	REN	P00797	1/20	0.31

▸	CTSD	P07339	1/20	0.31

▸	CTSE	P14091	1/20	0.31

▸	BACE1	P56817	1/20	0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL21781915	0.95	CYP3A4 (0.50)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL21781933	0.95	CYP3A4 (0.50)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL21781738	0.95	CYP3A4 (0.50)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL22068460	0.94	CYP3A4 (0.51)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL22068559	0.94	CYP3A4 (0.51)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL21781809	0.92	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL21781979	0.92	CYP3A4 (0.46)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL22068555	0.91	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL22068554	0.91	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2AKT1
SCHEMBL22068551	0.91	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3617221-A1	CYTOTOXIN AND CONJUGATE, USES OF SAME, AND PREPARATION METHOD THEREFOR	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN)	2020-03-04	—	—	EP	disclosed